Serum levels of Th2 cytokine IL-13 were found to be elevated in NASH patients, accompanied by increased hepatic expression levels of its receptor IL-13Rα2 (71). This evidence concerns the gene IL13 and metabolic dysfunction-associated steatohepatitis.